The number of patients with chronic kidney disease is increasing, while healthcare costs for these patients are disproportionately high. Home therapy can reduce costs and make the process more comfortable for patients, says startup company Peripal. However, due to risk of infection and increasing age, most patients continue to opt for dialysis in hospitals.
The Zurich-based startup company has developed a device for patients who need a peritoneal dialysis. PeriSafe – as the device is called – can prevent infection and simplify the therapy process, according to the company. In March, PeriSafe received approval for the European market. Since August, it has been reimbursed by three Swiss health insurance companies – Helsana, Sanitas und KPT. These three health insurance companies cover around one quarter of the Swiss population, writes a statement.
“It is of such great importance that healthcare systems support new and innovative approaches to existing markets”, commented Dr. Sandra Neumann, CEO of Peripal. “As a young company, we are very proud of having achieved this important milestone and we are very happy to have gained the endorsement of three important Swiss Health Insurance Companies.”
Peripal is a spinoff from the Federal Institute of Technology in Zurich (ETH) and is headquartered in Zurich.
Weitere News
Contact us
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?
info@greaterzuricharea.com